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 Age-related macular degeneration, a leading cause of ir-
reversible blindness in people over age 65 years [1-3], is char-
acterized by soft drusen, retinal pigmentary disturbances, and/
or focal retinal atrophy. Pathologically, drusen are localized
sub-retinal pigment epithelium (sub-RPE) deposits, abnormal
accumulation of extracellular material located between the
RPE and Bruch’s membrane [2]. Considerable information has
been accumulated on the morphology, ultrastructure, and mo-
lecular constituents of these deposits. However, the source(s)
of sub-RPE deposits and how they are formed remain enig-
matic [2,4-7]. RPE cells were suspected to give rise to drusen
when they were first described some 150 years ago [8,9]. Later,
choroid was suggested as their source [10]. Local immune-
mediated processes were implicated in drusen biogenesis as
well [5]. Animals that lack monocyte chemoattractant protein-
1 (MCP-1, also known as CCP-1) or its cognate C-C receptor-
2 (Ccr-2) [11], or that lack collagen XVIII/endostatin [12] are
shown to develop sub-RPE deposits/drusen. Recent findings
that variants in complement factor H [13-16], B, complement
component 2 (C2) [17], and LOC387715/HTRA1 [18,19]
genes may increase the risk to develop age-related macular
degeneration (AMD) provide insight into the pathological pro-
cess of AMD.
The exudative form of AMD, a major cause of severe
vision loss, is characterized by choroidal neovascularization
(CNV) as new blood vessels from the choroid penetrate
Bruch’s membrane to enter the retina. The mechanism of CNV
development is not fully understood. Pathological studies have
demonstrated a strong association between sub-RPE deposits
and CNV [20-23]. In addition, focal inflammation has been
found to induce focal thinning and breaks of Bruch’s mem-
brane in patients with AMD, along with a phenotypic switch
of local choroidal endothelial cells from quiescent to angio-
genic [24,25], suggesting the involvement of sub-RPE depos-
its. Nevertheless, it is not clear whether sub-RPE deposits and
CNV are simply two independent manifestations of the same
disease, or if the deposits play a role in CNV development.
Using Matrigel to create an amorphous deposit in the
subretinal space in rats, we demonstrate that RPE transloca-
tion displaces the Matrigel deposit to the sub-RPE location.
Subsequently, new blood vessels from the choriocapillaris
penetrate Bruch’s membrane and enter the Matrigel deposit.
These data support a novel mechanism of sub-RPE deposit
formation in which RPE translocation plays a central role in
converting subretinal material into sub-RPE deposits.
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Purpose: A cardinal pathological feature of age-related macular degeneration (AMD) is the deposition of extracellular
material between the retinal pigment epithelium (RPE) and Bruch’s membrane, pathologically described as sub-RPE
deposits. Both the presence and local organization of these deposits contribute to the clinical manifestations of AMD,
including localized deposits clinically recognized as drusen. The biogenesis of sub-RPE deposits remains elusive. This
work explores the pathological processes of sub-RPE deposit formation.
Methods: Matrigel was injected to the subretinal space of rats to create an amorphous deposit. Tissue sections were
examined by light or confocal microscopy.
Results: In the presence of the subretinal deposit of Matrigel, RPE cells leave Bruch’s membrane to migrate toward
photoreceptors and then form a new layer between the deposit and photoreceptors, resulting in RPE translocation. The
new RPE layer displaces the deposit to the sub-RPE location and therefore it becomes a sub-RPE deposit. The RPE
mobilization requires the presence of photoreceptors. Bruch’s membrane devoid of RPE attachment becomes vulnerable
to invasion by new blood vessels from the choroid.
Conclusions: Our work supports a novel model of sub-RPE deposit formation in which excessive material first accumu-
lates in the subretinal space, disrupting the physical contact between RPE cells and photoreceptors. To restore the contact,
RPE cells migrate toward photoreceptors and form a new layer. The subretinal material is consequently displaced to the
sub-RPE location and becomes sub-RPE deposit. Our data also provide evidence that the presence of sub-RPE deposit is
sufficient to induce choroidal neovascularization to penetrate Bruch’s membrane.
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873METHODS
Animals and subretinal injections:  All procedures involving
animals were approved by the Institutional Animal Care and
Use Committee of the University of Pennsylvania and adhered
to the Association for Research in Vision and Ophthalmology
Statement for the Use of Animals in Ophthalmic and Vision
Research. Adult Sprague-Dawley and Long Evans rats (fe-
male, 2-3 months old) were purchased from Harlan Laborato-
ries (Indianapolis, IN). Pigmented heterozygous transgenic rats
carrying a murine rhodopsin mutation S334ter were produced
by mating homozygous breeders of male S334ter transgenic
rats (Sprague-Dawley background) with wild-type Long Evans
females.
Subretinal injections of Matrigel (growth factor reduced,
BD Biosciences, Bedford, MA) were performed on the tem-
poral side of an eye under a microscope. A rat was anesthe-
tized by intraperitoneal injection of ketamine (40 mg/kg) and
xylazine (6 mg/kg). The sclera was exposed and an incision
was made between the limbus and the equator with a sharp
number 33 needle to reach the subretinal space. The tip of a
blunt number 33 needle attaching to a Hamilton micro-syringe
was introduced to the incision at a 5 degree angle toward the
posterior pole and inserted 0.1-0.2 mm into the subretinal
space. Matrigel was diluted with phosphate buffered saline
(PBS) at 3:1 (75% gel). Gel solution (1.2 µl) was slowly in-
jected so the solution pushed its way into the subretinal space.
Injected solution normally solidified within minutes and
formed a bleb of 1.5-2 mm in diameter with the injection site
at the anterior edge (Figure 1).
Histology:  Animals were sacrificed by CO2 overdose and
perfused with 2% paraformaldehyde and 2.5% glutaraldehyde
(in 0.1 M phosphate buffer, pH 7.4). Eyes were collected and
post-fixed in the same fixative. The posterior segments of the
eyes were embedded in an Epon-Araldite mixture [26]. Semi-
thin sections (1 µm) were cut through Matrigel injected areas,
stained with toluidine blue, and examined by light micros-
copy.
Visualization of blood vessels:  Blood vessels were di-
rectly labeled with a solution containing a fluorescent
carbocyanine dye DiI (1, 1'-Dioctadecyi-3, 3, 3', 3'-
tetramethylindocarbocyanine perchlorate, Sigma-Aldrich, St.
Louis, MO). An animal was sacrificed by CO2 overdose and
perfused with PBS (4-5 ml), followed by a solution contain-
ing 160 mM DiI (4-5 ml). The animal was subsequently per-
fused with 4% paraformaldehyde (20 ml in 0.1M phosphate
buffer, pH 7.4). Eyes were harvested and the anterior segments
removed. The eyecups were post-fixed in the same fixative
overnight and then transferred to PBS at 4 °C. Tissue was
embedded in 5% agarose. Thick (100 µm) serial sections were
cut on a vibratome (VT1000S, Leica Microsystems,
Bannockburn, IL), mounted on glass slides with 80% glyc-
erol, and examined by confocal microscopy.
RESULTS
Retinal pigment epithelium cell migration after subretinal in-
jection of Matrigel:  After injection, Matrigel formed a layer
between photoreceptors and the RPE (Figure 2A). RPE cells
remained in their original position attached to Bruch’s mem-
brane. Some small vesicles appeared between the tips of pho-
toreceptor outer segments and the inner surface of the Matrigel
layer (Figure 2A).
Active mobilization of RPE cells was seen as early as 5
days after injection of Matrigel (Figure 2B-D). In Figure 2B,
a small piece of gel (Figure 2B, white arrowhead) had been
relocated to the space between the RPE and Bruch’s mem-
brane, covered by two RPE cells. This piece of gel thus be-
came a sub-RPE deposit. The relocation process is vividly
displayed in the same retinal section. Two RPE cells close to
the tip of the of the main gel body (Figure 2B, black arrow-
head) had dissociated from each other and partially detached
from Bruch’s membrane to form a gap. The tip of the gel was
entrapped in the gap and was in direct contact with Bruch’s
membrane. The cell at the gel tip was extending into the space
between photoreceptors and the gel (Figure 2B).
At the edge of the Matrigel deposit, RPE cells circum-
vented the gel by extending into the space between photore-
ceptors and the gel (white arrowhead, Figure 2C), or directly
migrating to the photoreceptor side of the gel (black arrow-
head, Figure 2C). In the central region of the gel body, RPE
cells directly migrate to the photoreceptor side (Figure 2D).
Formation of a new retinal pigment epithelium layer af-
ter injection of Matrigel:  After migrating to the photorecep-
tor side, RPE cells formed a monolayer and reestablished di-
rect contact with photoreceptors. The formation of a new RPE
layer occurred as early as 10 days after Matrigel injection (Fig-
ure 3A). Some cells formed a bridge between Bruch’s mem-
brane and the new RPE layer, perhaps in the process of mi-
grating. A few cells remained in the original location, attached
to Bruch’s membrane, (Figure 3A). Comparable new RPE lay-
ers were found 25 days (Figure 3B), 30 days (Figure 3C), and
45 days (Figure 3D) after Matrigel injection, indicating that
the migration stabilized once the new layer had been formed.
In some cases, the Matrigel deposit was infiltrated by cells to
form a scar-like structure (Figure 3D). Shortening of photore-
ceptor outer segments and certain degree of photoreceptor de-
generation were also seen (Figure 3).
Photoreceptors are necessary for retinal pigment epithe-
lium migration:  The above findings indicate that when
Matrigel disrupts the direct RPE-photoreceptor contact, RPE
cells circumvent the Matrigel layer to reestablish the contact.
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Figure 1. Schematic illustration of subretinal injection.  The tip of a
blunt needle is introduced to the subretinal space (Sp) at a shallow
angle toward the posterior pole. Injected material formed a bleb (shade
area) in the subretinal Sp. Sc indicates sclera; Ch indicates choroid;
Rt indicates retina.
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Figure 2. Retinal pigment epithelium cells mobilization in response to subretinal Matrigel.  The position of Bruch’s membrane is indicated by
a horizontal white arrow in each panel. A: The edge of Matrigel layer in the subretinal space is shown 1 day after injection. No retinal pigment
epithelium (RPE) cells mobilization is detected. RPE mobilization was detected 5 days after injection of Matrigel (B-D). In B, a small piece of
gel (white arrowhead) had been relocated to the sub-RPE space. On the left side of the same retinal section, two RPE cells formed a gap,
entrapping the tip of the main gel body (black arrowhead). The gel tip was thus in direct contact with Bruch’s membrane. C: A cell at the edge
of the gel (white arrowhead) extended between photoreceptors and the gel. Another had migrated to the photoreceptor side of the gel (black
arrowhead). D: In the central region of the Matrigel layer, many cells had migrated to the photoreceptor side. Ch indicates choroid; M indicates
Matrigel layer; IS indicates inner segments; ONL indicates outer nuclear layer. The scale bar represents 20 µm.
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Figure 3. Formation of a new retinal pigment epithelium layer.  A: A new monolayer (black arrowheads) formed between the Matrigel (M) and
photoreceptors 10 days after Matrigel injection, displacing the Matrigel to the sub-RPE location. Comparable new retinal pigment epithelium
(RPE) layers (black arrowheads) were seen (Bruch’s membrane is indicated by white arrowheads) 25 days (B), 30 days (C), and 45 days (D)
after Matrigel injection. In some cases, the Matrigel injected area (M) was filled with cells to form scare-like tissue (D). The scale bar
represents 20 µm.
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Figure 4. No retinal pigment epithelium translocation in the absence of photoreceptors.  Eyes were obtained from the S334ter transgenic rats
15 days (A) or 45 days (B) after Matrigel injection. No photoreceptors or outer nuclear layer were identifiable. The Matrigel layer (M) was
between the retinal pigment epithelium (RPE) and the rest of the neuronal retina. RPE cells attached to Bruch’s membrane. No obvious RPE
migration is detected. No new RPE layer formed on the retinal side of the Matrigel layer. Significant hyperpigmentation occurred in the RPE
(B). INL indicates inner nuclear layer. The scale bar represents 20 µm.
Figure 5. Choroidal neovascularization induced by Matrigel deposit.  A: A differential interference contrast (DIC) image shows the posterior
edge of a Matrigel deposit. A new blood vessel from the choriocapillaris had penetrated Bruch’s membrane (between white arrowheads) at the
site indicated by a white arrow. A new retinal pigment epithelium (RPE) layer (asterisks) had formed between the Matrigel deposit and
photoreceptor outer segments (OS). B: The new blood vessel and the choriocapillaris are clearly shown in a confocal image (red). C: The DIC
image in A superimposed on the confocal image in B. The scale bar represents 20 µm.
877We hypothesize that the directional migration of RPE cells is
chemotactic in nature and photoreceptors are the target. To
test this hypothesis, we used animals with virtually no photo-
receptors. Transgenic rats carrying the rhodopsin mutation
S334ter undergo rapid photoreceptor degeneration: more than
90% of photoreceptors are lost by postnatal day (PD) 20 and
almost all are degenerated by PD30 [27,28]. We therefore chose
PD30 animals for subretinal injection of Matrigel. RPE cells
in these animals remained in their original location 15 days
after Matrigel injection (Figure 4A). No RPE migration oc-
curred even 45 days after injection (Figure 4B). Thus, RPE
migration and translocation require a signal from photorecep-
tors. We cannot rule out the possibility that RPE cells might
have changed in these animals in the absence of photorecep-
tors.
Induction of choroidal neovascularization after injection
of Matrigel:  We used this model to investigate the role of
sub-RPE deposits in CNV development. To avoid any new
blood vessels that might have been induced by the needle in-
jury to Bruch’s membrane during injection, we looked for new
blood vessels traversing Bruch’s membrane in a region dis-
tinct from the injection site. Since the posterior half of the
injected area was unambiguously separate from the injection
site and not touched by the injecting needle (Figure 1), we
were specifically looking for new blood vessels penetrating
Bruch’s membrane in the posterior half of the Matrigel area.
We identified new blood vessels in many samples col-
lected 45 days after injection of Matrigel in the posterior half
of the injected area. A representative one is shown in Figure 5.
This blood vessel originated from the choriocapillaris and
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Figure 6. Schematic illustration
of RPE translocation and sub-
RPE deposit formation.  A: Nor-
mal retina. B: A deposit (shade
area) has formed in the subretinal
space, which disrupts direct con-
tact between photoreceptor outer
segment (OS) and the retinal pig-
ment epithelium (RPE). RPE
cells leave Bruch’s membrane
(BM) and migrate toward photo-
receptors (indicated by open ar-
rows). C: The cells then form a
new layer between the deposit
and photoreceptors to reestablish
RPE-photoreceptor contact, re-
sulting in RPE translocation. The
deposit, originally in the
subretinal space, becomes a sub-
RPE deposit. D: Bruch’s mem-
brane devoid of RPE attachment
is susceptible to invasion of new
blood vessels from the choroid
(Ch).
878crossed Bruch’s membrane at a position close to the posterior
edge of the Matrigel deposit (Figure 5).
DISCUSSION
 The present work has revealed a remarkable ability of RPE
cells to reestablish direct contact with photoreceptors when
the contact is disrupted by excessive extracellular material in
the subretinal space. We have also demonstrated that RPE cells
circumvent the subretinal material by translocation and rees-
tablishing a new layer between photoreceptors and the
subretinal material, and therefore relocating the subretinal
material to sub-RPE space. Our work thus revealed a novel
mechanism of sub-RPE deposit formation in which extracel-
lular material first accumulates in the subretinal space, sepa-
rating the RPE from photoreceptors (Figure 6A,B). To rees-
tablish direct contact with photoreceptors, RPE cells migrate
toward photoreceptors and form a new RPE layer, which is
equivalent to translocation of the RPE layer. Because of the
translocation, there is a switch of positions between the origi-
nal RPE and the deposit (Figure 6C). Since the RPE is nor-
mally used as a reference to describe the surrounding struc-
tures, the location of the deposit after RPE translocation is
therefore in the sub-RPE space and it becomes a sub-RPE
deposit (Figure 6C).
Our work also provides an insight into the mechanism of
CNV development. When RPE cells migrate from Bruch’s
membrane, the RPE-Bruch’s membrane complex is dis-
mantled. It seems that the bare Bruch’s membrane devoid of
RPE is no longer recognized as a barrier and it becomes vul-
nerable to CNV invasion (Figure 6D). Our data therefore em-
phasize the importance of RPE as a barrier to CNV invasion,
possibly by producing PEDF (pigment epithelium derived fac-
tor), a potent antiangiogenic protein [29], and/or through con-
tact inhibition. The observation that cell infiltration is com-
mon in samples with CNV (Figure 5A,C) is consistent with
pathological findings from AMD patients to suggest an in-
volvement of focal inflammation [24,25]. Furthermore, the
deposits may provide a favorable microenvironment for new
blood vessels to extend and form a network once they pen-
etrate Bruch’s membrane. Therefore, a sub-RPE deposit may
serve as a nidus for pathological reactions that lead to CNV
development. However, we cannot rule out the possibility that
some components in the Matrigel were responsible for induc-
ing CNV to penetrate Bruch’s membrane.
Accumulation of extracellular proteins in the subretinal
space is commonly seen in patients with exudative retinal de-
tachments, often accompanied by drusen. For example, chronic
serous retinal detachment is closely associated with drusen
[5]. In addition, serous or exudative retinal detachment in cho-
roidal melanomas is accompanied by drusen-like structures
[30-32]. These findings are consistent with the hypothesis that
excessive extracellular material in the subretinal space leads
to the formation of sub-RPE deposit. Extracellular material
accumulation in the subretinal space has also been found in
adult vitelliform macular degeneration [33,34]. In our experi-
ments, the subretinal deposit was introduced at a large scale.
However, it is conceivable that micro-scaled, clinically unde-
tectable amounts of subretinal deposit could lead to repetitive
translocation of the RPE and formation of a macro-scaled sub-
RPE deposit.
RPE cells are housekeepers for photoreceptors. They not
only are essential for photoreceptor metabolism, but also par-
ticipate in the RPE-Bruch’s membrane complex to form the
blood-retinal barrier. It is clear that when the RPE-photore-
ceptor contact is disrupted, priority is given to reestablishing
the RPE-photoreceptor contact rather than maintaining the
RPE-Bruch’s membrane complex. Our data also provide a clue
to how the trophism of RPE cells and the dynamic nature of
the RPE-photoreceptor relationship are maintained: a signal
from photoreceptors. Although the nature of the signal is yet
to be identified, it is highly probable that the messenger is a
diffusible factor since it acts across a Matrigel layer. In this
regard, it is unlikely that in our experiments Matrigel itself
contains a molecule that triggered RPE translocation. In fact,
in the absence of photoreceptors, Matrigel failed to stimulate
RPE migration. Furthermore, we observed comparable RPE
cell translocation using collagen I gel instead of Matrigel (data
not shown).
In summary, our present work demonstrates that the pres-
ence of a subretinal deposit induces RPE cell translocation,
which in turn generates pathological features characteristic of
AMD, including formation of the sub-RPE deposit and CNV.
These findings indicate a subretinal source of sub-RPE de-
posits and a key role of RPE translocation in the formation of
sub-RPE deposits. Our data also provide evidence that the
presence of sub-RPE deposits is sufficient to induced CNV to
penetrate Bruch’s membrane.
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